Business

Analysts Expect Genomic Health, Inc. (GHDX) Will Announce Quarterly Sales of ...


Brokerages expect Genomic Health, Inc. (NASDAQ:GHDX) to post $94.53 million in sales for the current fiscal quarter, according to Zacks Investment Research .


Jefferies Financial Group reissued a “hold” rating and issued a $50.00 price objective on shares of Genomic Health in a report on Friday, August 3rd.


Finally, Canaccord Genuity boosted their price objective on Genomic Health from $56.00 to $62.00 and gave the company a “buy” rating in a report on Friday, August 3rd.


SG Americas Securities LLC acquired a new position in shares of Genomic Health during the second quarter worth approximately $162,000.


Teacher Retirement System of Texas acquired a new position in shares of Genomic Health during the second quarter worth approximately $213,000.


It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions.






Powered by Blogger.